These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11768201)

  • 1. Statin given perorally to adult rats increases cancellous bone mass and compressive strength.
    Oxlund H; Dalstra M; Andreassen TT
    Calcif Tissue Int; 2001 Nov; 69(5):299-304. PubMed ID: 11768201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simvastatin treatment partially prevents ovariectomy-induced bone loss while increasing cortical bone formation.
    Oxlund H; Andreassen TT
    Bone; 2004 Apr; 34(4):609-18. PubMed ID: 15050891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of a glucocorticoid with depot effect counteracts the stimulating effect of growth hormone on cancellous and cortical bone of the vertebral body in rats.
    Ortoft G; Oxlund H; Andreassen TT
    Calcif Tissue Int; 1998 Jul; 63(1):14-21. PubMed ID: 9632841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone increases cortical and cancellous bone mass in young growing rats with glucocorticoid-induced osteopenia.
    Ortoft G; Andreassen TT; Oxlund H
    J Bone Miner Res; 1999 May; 14(5):710-21. PubMed ID: 10320519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure.
    Jiang Y; Zhao JJ; Mitlak BH; Wang O; Genant HK; Eriksen EF
    J Bone Miner Res; 2003 Nov; 18(11):1932-41. PubMed ID: 14606504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of alendronate and alfacalcidol on cancellous and cortical bone mass and bone mechanical properties in ovariectomized rats.
    Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Yeh JK
    Exp Anim; 2006 Jul; 55(4):357-67. PubMed ID: 16880683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lasofoxifene (CP-336,156) protects against the age-related changes in bone mass, bone strength, and total serum cholesterol in intact aged male rats.
    Ke HZ; Qi H; Chidsey-Frink KL; Crawford DT; Thompson DD
    J Bone Miner Res; 2001 Apr; 16(4):765-73. PubMed ID: 11316005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin did not prevent nor restore ovariectomy-induced bone loss in adult rats.
    Yao W; Farmer R; Cooper R; Chmielewski PA; Tian XY; Setterberg RB; Jee WS; Lundy MW
    J Musculoskelet Neuronal Interact; 2006; 6(3):277-83. PubMed ID: 17142950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of growth hormone on cancellous and cortical bone of the vertebral body in aged rats.
    Andreassen TT; Melsen F; Oxlund H
    J Bone Miner Res; 1996 Aug; 11(8):1094-102. PubMed ID: 8854245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-resolution computed tomography for architectural characterization of human lumbar cancellous bone: relationships with histomorphometry and biomechanics.
    Cendre E; Mitton D; Roux JP; Arlot ME; Duboeuf F; Burt-Pichat B; Rumelhart C; Peix G; Meunier PJ
    Osteoporos Int; 1999; 10(5):353-60. PubMed ID: 10591832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the selective estrogen receptor modulator ospemifene on bone in rats.
    Kangas L; Härkönen P; Väänänen K; Peng Z
    Horm Metab Res; 2014 Jan; 46(1):27-35. PubMed ID: 24108389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simvastatin enhances bone formation around titanium implants in rat tibiae.
    Ayukawa Y; Ogino Y; Moriyama Y; Atsuta I; Jinno Y; Kihara M; Tsukiyama Y; Koyano K
    J Oral Rehabil; 2010 Feb; 37(2):123-30. PubMed ID: 19889034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cortical and cancellous bone formation in glucocorticoid-treated OVX sheep.
    Schorlemmer S; Ignatius A; Claes L; Augat P
    Bone; 2005 Oct; 37(4):491-6. PubMed ID: 16046208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interrelationships between bone microarchitecture and strength in ovariectomized monkeys treated with teriparatide.
    Chen P; Jerome CP; Burr DB; Turner CH; Ma YL; Rana A; Sato M
    J Bone Miner Res; 2007 Jun; 22(6):841-8. PubMed ID: 17352652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skeletal effects of bazedoxifene paired with conjugated estrogens in ovariectomized rats.
    Komm BS; Vlasseros F; Samadfam R; Chouinard L; Smith SY
    Bone; 2011 Sep; 49(3):376-86. PubMed ID: 21658483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment of indomethacin reduces vertebral bone mass and strength in ovariectomized rats.
    Saino H; Matsuyama T; Takada J; Kaku T; Ishii S
    J Bone Miner Res; 1997 Nov; 12(11):1844-50. PubMed ID: 9383689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stiffening effects of cortical bone on vertebral cancellous bone in situ.
    Bryce R; Aspden RM; Wytch R
    Spine (Phila Pa 1976); 1995 May; 20(9):999-1003. PubMed ID: 7631248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alfacalcidol prevents age-related bone loss and causes an atypical pattern of bone formation in aged male rats.
    Li M; Healy DR; Li Y; Simmons HA; Su M; Jee WS; Shen VW; Thompson DD
    J Musculoskelet Neuronal Interact; 2004 Mar; 4(1):22-32. PubMed ID: 15615075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat.
    Zhou H; Shen V; Dempster DW; Lindsay R
    J Bone Miner Res; 2001 Jul; 16(7):1300-7. PubMed ID: 11450706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe bone alterations under beta2 agonist treatments: bone mass, microarchitecture and strength analyses in female rats.
    Bonnet N; Benhamou CL; Brunet-Imbault B; Arlettaz A; Horcajada MN; Richard O; Vico L; Collomp K; Courteix D
    Bone; 2005 Nov; 37(5):622-33. PubMed ID: 16157516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.